NCT01926652View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

candesartan cilexetil 32mg, amlodipine 10mg

"Part A: Treatment A (candesartan), Treatment B (candesartan + amlodipine) 2-period, 2-treatment crossover.~Part B: Treatment A (Amlodipine), Treatment B (candesartan + amlodipine) 2-period, 2-treatment crossover."

Trial Locations (1)

301-721

Chungnam national university hospital, clinical trial center, Daejeon

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT01926652 - Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg | Biotech Hunter | Biotech Hunter